ATLAS / Macro Radar / Reporting / GTBP

GT Biopharma, Inc. (GTBP) reporting calendar

GT Biopharma, Inc. files periodic reports with the SEC as GTBP on Nasdaq. Atlas tracks 97 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
6 Aug 2026 – 22 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
15 May 2026
Reports on record
97

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 45 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open GTBP market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202615 May 202645 days0001493152-26-023346
10-K31 Dec 20252 Mar 202661 days0001493152-26-008443
10-Q30 Sep 202514 Nov 202545 days0001493152-25-023400
10-Q30 Jun 202514 Aug 202545 days0001493152-25-011971
10-Q31 Mar 202515 May 202545 days0001641172-25-010790
10-K31 Dec 202421 Feb 202552 days0001493152-25-007908
10-Q30 Sep 202414 Nov 202445 days0001493152-24-045892
10-Q30 Jun 202414 Aug 202445 days0001493152-24-032143
10-Q31 Mar 202415 May 202445 days0001493152-24-019970
10-K31 Dec 202326 Mar 202486 days0001493152-24-011332
10-Q30 Sep 20231 Nov 202332 days0001493152-23-038957
10-Q30 Jun 20237 Aug 202338 days0001493152-23-026973
10-Q31 Mar 202315 May 202345 days0001493152-23-017492
10-K31 Dec 202230 Mar 202389 days0001493152-23-009812
10-Q30 Sep 202231 Oct 202231 days0001493152-22-030019
10-Q30 Jun 202215 Aug 202246 days0001493152-22-022629
10-Q31 Mar 202216 May 202246 days0001493152-22-013539
10-K31 Dec 202128 Mar 202287 days0001493152-22-007883
10-Q30 Sep 202110 Nov 202141 days0001654954-21-011973
10-Q30 Jun 202123 Aug 202154 days0001654954-21-009366
10-Q31 Mar 202117 May 202147 days0001654954-21-005897
10-K31 Dec 202016 Apr 2021106 days0001654954-21-004295
10-Q30 Sep 202013 Nov 202044 days0001654954-20-012364
10-Q30 Jun 202014 Aug 202045 days0001654954-20-009193
10-Q31 Mar 202015 May 202045 days0001654954-20-005654
10-K31 Dec 201927 Mar 202087 days0001654954-20-003380
10-Q30 Sep 201914 Nov 201945 days0001654954-19-012975
10-Q30 Jun 201914 Aug 201945 days0001654954-19-009581
10-Q31 Mar 201915 May 201945 days0001654954-19-006086
10-K31 Dec 201829 Mar 201988 days0001654954-19-003697
10-Q30 Sep 201814 Nov 201845 days0001654954-18-012574
10-Q30 Jun 201814 Aug 201845 days0001654954-18-009126
10-Q31 Mar 201815 May 201845 days0001654954-18-005412
10-K31 Dec 20171 Mar 201860 days0001654954-18-002054
10-Q30 Sep 201714 Nov 201745 days0001654954-17-010615
10-Q30 Jun 201711 Aug 201742 days0001654954-17-007377
10-Q31 Mar 201728 Apr 201728 days0001654954-17-003780
10-K31 Dec 201631 Mar 201790 days0001654954-17-002919
10-Q30 Sep 201614 Nov 201645 days0001654954-16-003996
10-Q30 Jun 201610 Aug 201641 days0001654954-16-001358

Source: SEC EDGAR company submissions for CIK 0000109657. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.